Last week, we had the pleasure of hosting our collaborator Professor Nilmar Moretti at our lab at Stockholm University. Prof. Moretti, who works at both the University of Montréal and the Federal University of São Paulo (UNIFESP), shared exciting insights from his research on Leishmania and protein acetylation during his visit.
We exchanged ideas about our ongoing projects on parasite biology, finding many similarities between our work on Plasmodium and his research on Leishmania. In his presentation, Prof. Moretti gave an in-depth look at how his lab investigates lysine deacetylases (DACs) and their critical role in Leishmania’s lifecycle. His team uses CRISPR-Cas9 to create mutant parasites, uncovering how DACs regulate parasite survival, differentiation, and infection progression. These discoveries open up exciting possibilities for developing new treatments, and we were particularly interested in hearing how these insights could impact therapeutic strategies.
Outside of the lab, we took the opportunity to introduce him to Swedish culture by attending a hockey game, cheering for AIK. It was a fun and memorable way to wrap up his visit and connect on a more personal level.
We’re excited to continue working with Prof. Moretti and his team, strengthening our collaboration in the study of parasites between Sweden and Brazil.
